Immediate Impact
1 by Nobel laureates 1 from Science/Nature 70 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Targeting and engineering long non-coding RNAs for cancer therapy
2024 Standout
Works of J. Hamilton being referenced
A phase 1 study to evaluate safety and tolerability of escalating single doses of the hepatitis B virus RNA interference drug ARC-521 in a healthy volunteer population
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| J. Hamilton | 63 | 117 | 152 | 120 | 13 | 444 | |
| Meredith Mahan | 21 | 70 | 171 | 134 | 27 | 485 | |
| Jessica Yang | 19 | 102 | 290 | 58 | 19 | 473 | |
| Bruno Cola | 41 | 36 | 241 | 171 | 26 | 416 | |
| J. C. Harvey | 35 | 126 | 126 | 110 | 20 | 457 | |
| Mehmet Kitapçı | 45 | 60 | 80 | 112 | 24 | 433 | |
| Michael Covinsky | 35 | 20 | 84 | 86 | 24 | 426 | |
| Stephen H. Leveson | 61 | 71 | 271 | 99 | 21 | 416 | |
| Waldemar Uhl | 28 | 88 | 177 | 161 | 26 | 429 | |
| William R. Richli | 88 | 95 | 162 | 109 | 22 | 450 | |
| Keith Baldwin | 38 | 72 | 303 | 90 | 18 | 467 |
All Works
Loading papers...